Pharmaceutical Technology

NOVEMBER 23, 2023

The fast track designation for the paediatric multi-food allergy therapy ADP101 was based on the Phase I/II data.

Allergies 147

Allergies 147

Pharmaceutical Technology

MAY 16, 2024

IgGenix is planning to initiate a clinical trial later this year investigating its peanut allergy monoclonal antibody IGXN001.

Allergies 147

Allergies Clinical Trials Clinical Trials Antibody 147

Pharmaceutical Technology

OCTOBER 10, 2024

According to Lancet Public Health, the incidence of probable food allergy more than doubled in England between 2008 and 2018.

Allergies 130

Allergies 130

Pharmaceutical Technology

DECEMBER 26, 2024

Allergen for Grass Pollen Allergy is under clinical development by Roxall Medizin and currently in Phase II for Grass Pollen Allergy.

Allergies 100

Allergies Clinical Development Development 100

Pharmaceutical Technology

DECEMBER 2, 2024

CBC Group has completed the strategic acquisition of UCB's mature neurology and allergy business in China for $680m.

Allergies 130

Allergies 130

Pharmaceutical Technology

DECEMBER 2, 2024

The EMA’s CHMP has endorsed expanding the use of Palforzia to toddlers aged one to three years with peanut allergies.

Allergies 130

Allergies 130

Pharmaceutical Technology

AUGUST 27, 2024

UCB has entered a divestment agreement in China to sell its mature neurology and allergy business to CBC Group and Mubadala for $680m.

Allergies 130

Allergies 130

Pharma Times

NOVEMBER 23, 2023

ADP101 is an oral immunotherapy to treat multi-food and single-food allergies - News - PharmaTimes

Allergies 133

Allergies 133

pharmaphorum

FEBRUARY 19, 2024

Fast approaching the end of its patent life, Roche and Novartis’ Xolair is going out with a bang, picking up a new approval as the first and only drug therapy for people with food allergies in the US.

Allergies 121

Allergies Medicine Drugs 121

Pharmaceutical Technology

DECEMBER 20, 2023

The FDA accepted the filing based on NIH-funded Phase III trial interim results, with an approval decision expected in Q1 2024

Allergies 244

Allergies Trials 244

Fierce Pharma

FEBRUARY 16, 2024

People with food allergies finally have a drug that can help prevent severe outcomes—and it’s a drug that’s been on the market for two decades. People with food allergies finally have a drug that can help prevent severe outcomes—and it’s a drug that’s been on the market for two decades.

Allergies 119

Allergies FDA Approval Marketing Medicine 119

Pharma Times

FEBRUARY 10, 2022

Research demonstrates that people who live with peanut allergies face isolation and discrimination

Allergies 113

Allergies Research 113

NPR Health - Shots

APRIL 2, 2023

Patients who have digestive symptoms only after eating red meat may have developed an allergy caused by ticks. Previously, doctors looked for symptoms such as rashes, hives and breathing troubles. Image credit: Getty Images)

Allergies 134

Allergies Doctor Doctors Development 134

pharmaphorum

OCTOBER 10, 2022

For the 32 million individuals in the US with food allergies, more research into symptoms, causes, and treatments has been long sought after, but historically underfunded. per person being spent on food allergy research. Luckily for those with food allergies, the food allergy sector has benefitted from this influx of funding.

Allergies 107

Allergies Marketing Production Doctors 107

Fierce Pharma

DECEMBER 19, 2023

On the market for two decades for asthma, Novartis and Roche’s Xolair is closing in on a new indication as a way for those with food allergies to avoid severe outcomes. | On the market for two decades for asthma, Novartis and Roche’s Xolair is closing in on a new indication as a way for those with food allergies to avoid severe outcomes.

Allergies 118

Allergies Marketing 118

pharmaphorum

DECEMBER 23, 2021

Children in England with peanut allergies could be among the first in Europe to get access to Aimmune’s oral immunotherapy Palforzia, after the drugmaker agreed a supply deal with NHS England. billion last year, is also developing immunotherapies for other indications including egg and multi-tree nut allergies.

Allergies 111

Allergies Drugs Clinical Trials Clinical Trials 111

Bio Pharma Dive

AUGUST 31, 2020

The Swiss firm will take over the launch of Aimmune's Palforzia, sales of which have disappointed since its approval in January.

Allergies 229

Allergies Sales 229

Medical Xpress

MAY 3, 2023

A new Nature Immunology study led by University of Pittsburgh and National Institutes of Health researchers sheds light on how a rare type of helper T cell, called Th9, can drive allergic disease, suggesting new precision medicine approaches to treating allergies in patients with high levels of Th9.

Allergies 122

Allergies Medicine Research 122

Delveinsight

AUGUST 2, 2021

Peanut allergy (PA) is one of the most common food allergies that affect children in Western nations. Historically, the gold standard of the treatment for Peanut allergy constituted a strategic plan for peanut avoidance coupled with an adrenaline auto-injector (AAI) in case of contingencies.

Allergies 97

Allergies Marketing Development Trials 97

Outsourcing Pharma

SEPTEMBER 16, 2021

The US agency has given the go-ahead to Cour Pharmaceuticals to evaluate the safety and efficacy of CNP-201, a drug intended to treat peanut allergies.

Allergies 105

Allergies FDA Approval Drugs Regulation 105

Bio Pharma Dive

JULY 18, 2022

The food giant will pay French company Enterome about $40 million to join in the development of an inflammatory bowel disease drug as well as other food allergy treatments.

Allergies 252

Allergies Drugs Development 252

Bio Pharma Dive

AUGUST 22, 2022

Fauci will leave his post as the director of the National Institute of Allergy and Infectious Diseases and as the president’s chief medical advisor.

Allergies 246

Allergies 246

Scienmag

DECEMBER 22, 2021

There have been many research efforts describing the nature and progression of dog allergies, but there have been very few applied studies that use this information to try to cure people of dog allergies entirely by artificially inducing immune tolerance.

Allergies 94

Allergies Research Vaccine Vaccination 94

Scienmag

FEBRUARY 8, 2021

Credit: William Anderegg If you live with seasonal allergies and feel like the pollen seasons feel longer and longer every year, you may be right. New research shows that pollen seasons start 20 days earlier, are 10 days longer, and feature 21% more pollen than in 1990–meaning more days of itchy, sneezy, drippy misery. Led […].

Allergies 98

Allergies Research 98

Medical Xpress

MAY 9, 2023

Having a latex allergy is no fun, but it can be a real challenge for health professionals who have to work with a wide variety of medical equipment that can contain the allergen.

Allergies 96

Allergies Containment 96

Medical Xpress

NOVEMBER 28, 2022

Philip Li from the LKS Faculty of Medicine, The University of Hong Kong (HKUMed) has pioneered a new nurse-led penicillin allergy triage and testing strategy—the Hong Kong Drug Allergy Delabelling Initiative (HK-DADI), and demonstrated its effectiveness and safety compared to traditional allergy testing.

Allergies 90

Allergies Nurses Medicine Drugs 90

Pharmaceutical Technology

DECEMBER 22, 2023

Regeneron Pharmaceuticals Inc granted patent for preventing or treating allergies. Learn about the method involving IL-4R antagonists and specific dosage instructions.

Allergies 100

Allergies 100

XTalks

JUNE 21, 2021

who is on a mission to help parents save their children from food allergies by providing them with a powder added to their milk bottles. Zakowski started this company because his nephew developed several severe food allergies. Related: Red Meat Allergy Test Gets FDA Clearance. The product is part of a three-step guidance system.

Allergies 97

Allergies Production FDA Approval Protein 97

Outsourcing Pharma

AUGUST 29, 2024

The European Commission has approved ARS Pharmaceuticalsâ adrenaline nasal spray for the emergency treatment of severe allergies, EURneffy.

Allergies 87

Allergies Drug Delivery Drugs 87

Pharma Times

MAY 12, 2022

The study is the UK’s most comprehensive allergy test, analysing 295 allergens, including well known potential food allergens

Allergies 100

Allergies Development 100

XTalks

JANUARY 17, 2023

The US Food and Drug Administration (FDA) has added sesame to its list of major allergens, making it easier for people with sesame allergies to safely consume packaged food without fear of an allergic reaction. Related: Top 3 Allergy Friendly Food Brands. percent of children and adults in the US are allergic to sesame.

Allergies 93

Allergies Packaging Packaging Containment 93

Scienmag

JANUARY 20, 2022

A clinical trial funded by the National Institutes of Health has found that giving peanut oral immunotherapy to highly peanut-allergic children ages 1 to 3 years safely desensitized most of them to peanut and induced remission of peanut allergy in one-fifth. The immunotherapy consisted of a daily oral dose of peanut flour for 2.5

Allergies 89

Allergies Trial Funding Clinical Trials Clinical Trials 89

Medical Xpress

DECEMBER 2, 2022

The presence of food-specific IgA antibodies in the gut does not prevent peanut or egg allergies from developing in children, according to a Northwestern Medicine study published in Science Translational Medicine.

Allergies 81

Allergies Antibody Medicine Development 81

NPR Health - Shots

OCTOBER 31, 2022

Trick-or-treaters with allergies have to be extra careful on Halloween — the Teal Pumpkin Project is making the day a little less scary for them.

Allergies 90

Allergies 90

Pharma Times

DECEMBER 10, 2020

Updated guidance warns people with a history of allergic reactions not to receive the shot

Allergies 146

Allergies 146

Scienmag

JULY 5, 2022

Scientists have revealed the genetic and molecular structure of key molecules linked to the sometimes life-threatening mammalian-meat allergy brought on by tick bites. The […].

Allergies 79

Allergies Genetics Scientist Research 79

XTalks

FEBRUARY 26, 2024

The class of IgE-mediated food allergies includes 160 foods, with peanuts, milk, eggs, wheat, soy and tree nuts being the most common ones. According to the Centers for Disease Control and Prevention (CDC), almost six percent of people in the US in 2021 had a food allergy. However, the treatment is restricted to peanut allergy.

Allergies 74

Allergies FDA Approval Drugs Protein 74